Commercial Services Healthcare Sector

Treace Medical Concepts

Market Cap: US$395.7m

A medical technology company, designs, manufactures, and markets medical devices in the United States.

Standard BioTools

Market Cap: US$395.0m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

Autolus Therapeutics

Market Cap: US$391.2m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Precigen

Market Cap: US$389.6m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Northwest Biotherapeutics

Market Cap: US$389.4m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

AngioDynamics

Market Cap: US$388.6m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

Tourmaline Bio

Market Cap: US$388.2m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Organogenesis Holdings

Market Cap: US$381.8m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Atai Life Sciences

Market Cap: US$381.6m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Fortrea Holdings

Market Cap: US$380.3m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Verve Therapeutics

Market Cap: US$377.1m

A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.

Myriad Genetics

Market Cap: US$375.2m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

Rigel Pharmaceuticals

Market Cap: US$374.2m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Australian Clinical Labs

Market Cap: AU$579.0m

Provides pathology diagnostic services in Australia.

Prothena

Market Cap: US$367.1m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Humacyte

Market Cap: US$363.0m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

SBC Medical Group Holdings

Market Cap: US$359.5m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Mereo BioPharma Group

Market Cap: US$356.2m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

TruBridge

Market Cap: US$350.7m

Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

Checkpoint Therapeutics

Market Cap: US$349.7m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Emergent BioSolutions

Market Cap: US$349.0m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Benitec Biopharma

Market Cap: US$348.4m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Alpha Teknova

Market Cap: US$347.4m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Erasca

Market Cap: US$345.6m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Absci

Market Cap: US$344.4m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

Olema Pharmaceuticals

Market Cap: US$342.8m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Anbio Biotechnology

Market Cap: US$342.4m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Cidara Therapeutics

Market Cap: US$340.5m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

ClearPoint Neuro

Market Cap: US$340.3m

Operates as a medical device company primarily in the United States.

Clinuvel Pharmaceuticals

Market Cap: AU$528.1m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Fulcrum Therapeutics

Market Cap: US$337.4m

A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

SNDL

Market Cap: US$337.1m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

NIOX Group

Market Cap: UK£250.8m

Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

NervGen Pharma

Market Cap: CA$466.4m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Nano-X Imaging

Market Cap: US$334.1m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

aTyr Pharma

Market Cap: US$333.8m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.